JULIA BORODAY: Open Payments
NPI 1841920949 · PORT WASHINGTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,256 in 191 payments from 14 companies in 2025. Trend: 2023 $16 · 2024 $0 · 2025 $3,256
Food & beverage: $3,256
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 70 | $1,116 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 48 | $748 |
| Janssen Biotech, Inc. | 28 | $471 |
| Ardelyx, Inc. | 23 | $358 |
| PFIZER INC. | 7 | $149 |
| Madrigal Pharmaceuticals | 2 | $85 |
| QOL Medical, LLC | 2 | $73 |
| Lilly USA, LLC | 4 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $63 |
| GENZYME CORPORATION | 1 | $36 |
Products named: XIFAXAN, RINVOQ, TREMFYA, IBSRELA, SKYRIZI, CREON, VELSIPITY, DUPIXENT.
Industry payments across NY — which companies pay providers there.
